What is Healthcare Tr Amer Inc's earnings per share (EPS)?

Healthcare Tr Amer Inc (HR) reported diluted earnings per share of -$0.71 for fiscal year 2025. This represents a 60.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthcare Tr Amer Inc (HR) Financials

Trailing 12 months to June 30, 2026

Revenue $1.1B -6.3% YoY

Net Income -$90.3M +78.1% YoY

EPS (Diluted) -$0.26 +77.6% YoY

Operating Cash Flow $441.2M -5.8% YoY

Market Cap $6.6B as of Sep 10, 2026

Price / Sales 5.7x on $1.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.6x on $4.2B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HR SEC filings page.

Healthcare Tr Amer Inc (HR) reported $1.1B in revenue over the twelve months to Jun 30, 2026, down 6.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HR FY2025 2026-08-29

Noncash depreciation masks positive property cash generation as the portfolio contracts and debt is paid down.

FY2025 paired a net loss of -$249M with operating cash flow of $457M, showing that accounting earnings and property-level cash generation are diverging. Depreciation and amortization was $564M, larger than the net loss in absolute terms, so noncash property charges heavily depress reported earnings without matching near-term cash movement one-for-one.

Cash conversion is not the same as distributable cash: dividends consumed 84.6% of operating cash flow in FY2025. Because free cash flow and capital expenditures are not reported here, operating cash flow alone cannot establish how much cash remained after property reinvestment.

Deleveraging occurred alongside portfolio contraction: debt fell from $4.66B to $3.91B between FY2024 and FY2025. Assets also declined, so the improved debt-to-equity posture reflects balance-sheet shrinkage rather than expansion financed with less leverage.

Financial Health Signals

Financial Health Score 22/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Healthcare Tr Amer Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Healthcare Tr Amer Inc scores 44/100 on it among other REITs.

FFO Growth

FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Healthcare Tr Amer Inc scores 18/100 on it among other REITs.

Leverage

Not available for Healthcare Tr Amer Inc, and counted as zero in the overall score.

Interest Cov.

Not available for Healthcare Tr Amer Inc, and counted as zero in the overall score.

AFFO Margin

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Healthcare Tr Amer Inc scores 47/100 on it among other REITs.

Dividend Cov.

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. Healthcare Tr Amer Inc scores 20/100 on it among other REITs.

Piotroski F-Score Partial

6/7

Healthcare Tr Amer Inc passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

N/A

Healthcare Tr Amer Inc reported a net loss of $249.5M while generating $457.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$281.8M

YoY-5.3%

QoQ+1.0%

5Y CAGR+8.4%

Healthcare Tr Amer Inc generated $281.8M in revenue in Q2 2026. This represents a decrease of 5.3% from the same quarter a year earlier. Against the prior quarter it is up 1.0%.

Net Income

-$43.5M

YoY+72.4%

QoQ-77603.6%

Healthcare Tr Amer Inc reported -$43.5M in net income in Q2 2026. This represents an increase of 72.4% from the same quarter a year earlier. Against the prior quarter it is down 77603.6%.

EPS (Diluted)

-$0.13

YoY+71.1%

Healthcare Tr Amer Inc earned -$0.13 per diluted share (EPS) in Q2 2026. This represents an increase of 71.1% from the same quarter a year earlier.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$19.0M

YoY-25.6%

QoQ-27.6%

5Y CAGR-0.8%

10Y CAGR+8.8%

Healthcare Tr Amer Inc held $19.0M in cash against $4.2B in long-term debt as of Q2 2026.

Dividends Per Share

$0.24

YoY-22.6%

QoQ0.0%

Healthcare Tr Amer Inc paid $0.24 per share in dividends in Q2 2026. This represents a decrease of 22.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

343M

YoY-2.5%

QoQ-1.1%

5Y CAGR+9.4%

10Y CAGR+9.5%

Healthcare Tr Amer Inc had 343M shares outstanding in Q2 2026. This represents a decrease of 2.5% from the same quarter a year earlier. Against the prior quarter it is down 1.1%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

-15.4%

YoY+37.6pp

QoQ-15.4pp

5Y CAGR-35.6pp

Healthcare Tr Amer Inc's net profit margin was -15.4% in Q2 2026, showing the share of revenue converted to profit. This is up 37.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 15.4 percentage points.

Return on Equity

-1.0%

YoY+2.3pp

QoQ-1.0pp

5Y CAGR-2.8pp

Healthcare Tr Amer Inc's ROE was -1.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$731K

YoY+46.8%

QoQ-64.2%

5Y CAGR-9.9%

10Y CAGR+6.6%

Healthcare Tr Amer Inc spent $731K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 46.8% from the same quarter a year earlier. Against the prior quarter it is down 64.2%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

HR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HR quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.1B	$1.2B-6.9%	$1.3B-5.6%	$1.3B+44.1%	$932.6M+74.4%	$534.8M+7.0%	$499.6M-27.8%	$692.0M-0.6%	$696.4M+13.4%	$614.0M+33.2%	$460.9M+14.1%	$403.8M+8.7%	$371.5M+15.5%	$321.6M+7.3%	$299.6M+10.1%	$272.2M
SG&A Expenses	$67.3M	$72.6M-12.7%	$83.1M+42.3%	$58.4M+10.8%	$52.7M+54.4%	$34.2M+11.2%	$30.7M-25.8%	$41.4M+17.5%	$35.2M+5.4%	$33.4M+16.1%	$28.8M+12.5%	$25.6M+2.5%	$24.9M+2.0%	$24.4M+12.5%	$21.7M+4.1%	$20.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$123.6M+21.3%	$101.9M+8.9%	$93.6M+12.7%	$83.1M+25.4%	$66.3M+117.8%	$30.4M-34.3%	$46.3M
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$368.6M+32.2%	$278.8M+12.5%	$247.7M+10.8%	$223.5M+18.9%	$187.9M+28.0%	$146.8M-3.9%	$152.9M
Interest Expense	$189.9M	$209.0M-13.8%	$242.4M-6.2%	$258.6M+76.3%	$146.7M+176.1%	$53.1M-5.4%	$56.2M-41.9%	$96.6M-5.1%	$101.8M+19.1%	$85.5M+43.0%	$59.8M+8.7%	$55.0M+6.6%	$51.6M+9.5%	$47.1M+16.6%	$40.4M+3.4%	$39.0M
Net Income	-$90.3M	-$249.5M+62.4%	-$663.9M-135.4%	-$282.1M-793.2%	$40.7M-39.0%	$66.7M-7.7%	$72.2M+139.4%	$30.2M-85.9%	$213.5M+234.0%	$63.9M+39.2%	$45.9M+39.4%	$32.9M-27.4%	$45.4M+87.0%	$24.3M+199.3%	-$24.4M-540.8%	$5.5M
EPS (Basic)	N/A	-$0.71+60.8%	-$1.81-144.6%	-$0.74-593.3%	$0.15-66.7%	$0.45-13.5%	$0.52+246.7%	$0.15-85.6%	$1.04+197.1%	$0.35+2.9%	$0.34+30.8%	$0.26-31.6%	$0.38+81.0%	$0.21+195.5%	-$0.22-1200.0%	$0.02
EPS (Diluted)	-$0.26	-$0.71+60.8%	-$1.81-144.6%	-$0.74-593.3%	$0.15	$0.45-13.5%	$0.52	$0.14-86.3%	$1.02+200.0%	$0.34+3.0%	$0.33+26.9%	$0.26-29.7%	$0.37	$0.21+195.5%	-$0.22	$0.02
Diluted Shares (Avg)	N/A	350M-4.3%	366M-3.5%	379M+49.3%	254M	143M+6.5%	134M	210M-0.2%	210M+13.4%	185M+32.1%	140M+9.6%	128M+5.6%	121M	115M+3.2%	111M	224M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$281.8M-5.3%	$279.0M-6.7%	$286.3M-7.6%	$297.8M-5.6%	$297.5M-5.9%	$299.0M-8.5%	$309.8M-6.3%	$315.4M-7.8%
SG&A Expenses	$14.4M-38.8%	$17.3M+28.2%	$13.8M-59.7%	$21.8M+8.2%	$23.5M+67.7%	$13.5M-8.5%	$34.2M+134.1%	$20.1M+50.2%
Interest Expense	$45.1M-15.4%	$43.9M-19.9%	$48.2M-17.3%	$52.6M-13.2%	$53.3M-14.6%	$54.8M-10.2%	$58.3M-7.8%	$60.6M-8.5%
Net Income	-$43.5M+72.4%	-$56K+99.9%	$11.0M+109.4%	-$57.7M+37.9%	-$157.9M-9.8%	-$44.9M+85.6%	-$116.3M-162.1%	-$93.0M-37.1%
EPS (Basic)	-$0.13+71.1%	$0.00+100.0%	$0.04+112.5%	-$0.17+34.6%	-$0.45-15.4%	-$0.13+84.1%	-$0.32-190.9%	-$0.26-44.4%
EPS (Diluted)	-$0.13+71.1%	$0.00+100.0%	$0.04+112.5%	-$0.17+34.6%	-$0.45-15.4%	-$0.13+84.1%	-$0.32-190.9%	-$0.26-44.4%
Diluted Shares (Avg)	342M-2.1%	347M-0.6%	N/A	350M-2.5%	350M-6.1%	350M-7.9%	N/A	359M-5.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.

HR Balance Sheet

HR quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$9.2B-13.5%	$10.7B-15.7%	$12.6B-8.8%	$13.8B+225.2%	$4.3B-37.3%	$6.8B+2.3%	$6.6B+7.3%	$6.2B-4.0%	$6.4B+72.1%	$3.7B+18.1%	$3.2B+4.6%	$3.0B+10.1%	$2.8B+14.0%	$2.4B+5.3%	$2.3B
Cash & Equivalents	$26.2M-62.0%	$68.9M+168.2%	$25.7M-57.8%	$61.0M+362.7%	$13.2M-88.6%	$115.4M+252.8%	$32.7M-74.1%	$126.2M+25.8%	$100.4M+793.6%	$11.2M-14.1%	$13.1M+25.5%	$10.4M-42.4%	$18.1M+13.3%	$16.0M-77.0%	$69.5M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$32.8M-10.1%	$36.5M-42.3%	$63.2M+15.6%	$54.7M+288.5%	$14.1M-20.6%	$17.7M+50.1%	$11.8M-19.1%	$14.6M-28.0%	$20.3M+132.4%	$8.7M+49.9%	$5.8M-51.1%	$11.9M-26.8%	$16.3M	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	$0-100.0%	$250.5M+12.2%	$223.2M+6301.0%	$3.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.5B-15.2%	$5.3B-6.5%	$5.7B-7.4%	$6.2B+197.4%	$2.1B-41.7%	$3.6B+10.8%	$3.2B+12.7%	$2.8B-7.5%	$3.1B+56.9%	$2.0B+11.5%	$1.8B+13.5%	$1.6B+15.0%	$1.3B+17.7%	$1.1B+59.0%	$720.5M
Long-Term Debt	$3.9B-16.1%	$4.7B-6.6%	$5.0B-6.7%	$5.4B+197.1%	$1.8B-40.5%	$3.0B+10.1%	$2.7B+8.2%	$2.5B-8.6%	$2.8B+57.2%	$1.8B+11.2%	$1.6B+13.4%	$1.4B+15.5%	$1.2B+17.1%	$1.0B+62.3%	$639.1M
Total Equity	$4.6B-11.8%	$5.2B-23.3%	$6.8B-9.9%	$7.6B+246.5%	$2.2B+12.2%	$1.9B-42.0%	$3.4B+3.1%	$3.3B-0.7%	$3.3B+94.3%	$1.7B+22.3%	$1.4B-4.7%	$1.4B+4.3%	$1.4B+10.6%	$1.3B-20.0%	$1.6B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$742.1M-17.1%	-$633.7M-35.6%	-$467.2M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$9.0B-12.1%	$9.1B-12.8%	$9.2B-13.5%	$9.9B-12.3%	$10.2B-13.3%	$10.5B-14.5%	$10.7B-15.7%	$11.2B-14.2%
Cash & Equivalents	$19.0M-25.6%	$26.2M+2.0%	$26.2M-62.0%	$43.3M+90.1%	$25.5M-38.9%	$25.7M-1.7%	$68.9M+168.2%	$22.8M-7.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	N/A	$32.8M-10.1%	N/A	N/A	N/A	$36.5M-42.3%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$0-100.0%
Total Liabilities	$4.7B-11.7%	$4.7B-13.1%	$4.5B-15.2%	$5.1B-9.4%	$5.4B-8.1%	$5.3B-7.4%	$5.3B-6.5%	$5.6B-5.8%
Long-Term Debt	$4.2B-11.2%	$4.1B-13.3%	$3.9B-16.1%	$4.5B-9.5%	$4.7B-8.8%	$4.7B-7.4%	$4.7B-6.6%	$5.0B-5.2%
Total Equity	$4.2B-12.5%	$4.4B-12.6%	$4.6B-11.8%	$4.7B-15.1%	$4.8B-18.2%	$5.1B-20.8%	$5.2B-23.3%	$5.5B-21.2%

Not reported in any period shown, so not listed: Current Assets, Inventory, Current Liabilities, Non-Current Liabilities, Retained Earnings.

HR Cash Flow Statement

HR quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$441.2M	$457.1M-8.9%	$501.6M+0.4%	$499.8M+83.3%	$272.7M+17.2%	$232.6M-50.5%	$470.1M+38.1%	$340.4M+0.9%	$337.4M+9.7%	$307.5M+51.0%	$203.7M+6.6%	$191.1M+13.4%	$168.5M+14.0%	$147.8M+26.6%	$116.8M+4.5%	$111.8M
Depreciation & Amortization	N/A	$564.0M-16.5%	$675.2M-7.6%	$730.7M+61.3%	$453.1M+123.5%	$202.7M+6.4%	$190.4M-34.4%	$290.4M+3.8%	$279.6M+14.1%	$245.0M+38.5%	$176.9M+14.7%	$154.1M+9.8%	$140.4M+15.4%	$121.6M+4.5%	$116.4M+9.3%	$106.6M
Stock-Based Compensation	N/A	$22.4M-29.7%	$31.8M+122.7%	$14.3M-29.8%	$20.3M+89.6%	$10.7M+8.1%	$9.9M-2.0%	$10.1M+3.8%	$9.8M+42.0%	$6.9M-2.8%	$7.1M+23.5%	$5.7M+30.6%	$4.4M-22.4%	$5.6M-67.6%	$17.4M+440.5%	$3.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$97.2M+30.0%	$74.7M-18.4%	$91.5M+17.6%	$77.9M+20.1%	$64.8M+50.8%	$43.0M+46.9%	$29.3M+0.8%	$29.0M+14.4%	$25.4M+10.8%	$22.9M+42.9%	$16.0M
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	$135.5M-65.7%	$395.3M+58.9%	$248.8M-4.1%	$259.5M+6.9%	$242.7M+51.0%	$160.7M-0.7%	$161.8M+16.0%	$139.5M+13.9%	$122.4M+30.4%	$93.9M-2.0%	$95.8M
Investing Cash Flow	$700.4M	$710.8M-21.1%	$900.9M+158.0%	$349.1M-78.6%	$1.6B+390.6%	-$562.5M-1.3%	-$555.2M+16.8%	-$667.3M-478.5%	$176.3M+107.2%	-$2.5B-303.5%	-$608.4M-121.9%	-$274.2M-5.6%	-$259.7M+30.7%	-$374.7M-32.1%	-$283.5M-329.9%	-$66.0M
Financing Cash Flow	-$1.1B	-$1.2B+10.9%	-$1.4B-53.7%	-$884.2M+52.4%	-$1.9B-667.4%	$327.7M+228.6%	$99.7M-56.8%	$231.0M+146.3%	-$498.7M-122.3%	$2.2B+459.2%	$400.8M+395.9%	$80.8M-3.2%	$83.5M-63.5%	$229.0M+102.3%	$113.2M+2111.8%	-$5.6M
Dividends Paid	$335.3M	$386.9M-15.5%	$457.9M-3.0%	$472.2M+66.5%	$283.7M+61.7%	$175.5M+7.9%	$162.6M-36.5%	$256.1M+1.4%	$252.7M+22.0%	$207.1M+30.1%	$159.2M+8.7%	$146.4M+6.7%	$137.2M+6.0%	$129.4M+38.7%	$93.3M+10.0%	$84.8M
Share Buybacks	$6.1M	$4.0M-54.9%	$8.9M+286.5%	$2.3M-28.0%	$3.2M-16.1%	$3.8M+164.8%	$1.4M-88.2%	$12.2M-82.7%	$70.3M+1960.3%	$3.4M+29.2%	$2.6M+58.5%	$1.7M+57.9%	$1.1M+102.3%	$522K-99.7%	$182.6M+384.6%	$37.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$142.2M-12.9%	$52.9M+10.6%	$132.3M-4.1%	$113.8M-4.7%	$163.2M-2.9%	$47.8M-37.2%	$138.0M+8.4%	$119.3M+0.9%
Depreciation & Amortization	$128.1M-16.6%	$129.0M-14.6%	$127.4M-20.5%	$137.8M-15.6%	$153.5M-11.5%	$151.0M-15.2%	$160.3M-11.0%	$163.2M-10.8%
Stock-Based Compensation	N/A	$5.4M+79.1%	N/A	N/A	N/A	$3.0M-15.0%	N/A	N/A
Investing Cash Flow	-$7.0M-126.6%	-$45.3M-16.7%	$526.5M+25.7%	$226.3M-31.6%	-$3.1M-101.5%	-$38.8M+33.7%	$418.8M+76.9%	$330.8M+178.9%
Financing Cash Flow	-$142.4M+11.1%	-$7.5M+85.6%	-$676.1M-31.5%	-$322.2M+30.8%	-$160.2M+55.8%	-$52.1M-204.6%	-$514.0M-41.6%	-$465.7M-87.7%
Dividends Paid	$82.2M-24.5%	$83.9M-22.9%	$84.4M-23.1%	$84.8M-24.6%	$108.9M-7.2%	$108.8M-8.0%	$109.8M-7.0%	$112.4M-4.8%
Share Buybacks	$731K+46.8%	$2.0M+849.3%	$379K-95.6%	$2.9M	$498K+16500.0%	$215K-32.4%	$8.6M+1744.8%	$0-100.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

HR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HR quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	20.1%-2.0pp	22.1%-1.1pp	23.2%+0.8pp	22.4%+1.8pp	20.6%+10.4pp	10.2%-6.9pp	17.0%
Net Margin	-21.1%+31.2pp	-52.3%-31.4pp	-21.0%-25.4pp	4.4%-8.1pp	12.5%-2.0pp	14.4%+10.1pp	4.4%-26.3pp	30.6%+20.2pp	10.4%+0.5pp	10.0%+1.8pp	8.2%-4.1pp	12.2%+4.7pp	7.5%+15.7pp	-8.2%-10.2pp	2.0%
Return on Equity	-5.4%+7.3pp	-12.7%-8.5pp	-4.1%-4.7pp	0.5%-2.5pp	3.0%-0.7pp	3.7%+2.8pp	0.9%-5.7pp	6.6%+4.6pp	1.9%-0.8pp	2.7%+0.3pp	2.4%-0.7pp	3.1%+1.4pp	1.8%+3.7pp	-1.9%-2.3pp	0.4%
Return on Assets	-2.7%+3.5pp	-6.2%-4.0pp	-2.2%-2.5pp	0.3%-1.3pp	1.6%+0.5pp	1.1%+0.6pp	0.4%-3.0pp	3.5%+2.5pp	1.0%-0.2pp	1.2%+0.2pp	1.0%-0.5pp	1.5%+0.6pp	0.9%+1.9pp	-1.0%-1.3pp	0.2%
Debt-to-Equity	0.850.0x	0.89+0.2x	0.730.0x	0.71-0.1x	0.82-0.7x	1.55+0.7x	0.820.0x	0.78-0.1x	0.85-0.2x	1.05-0.1x	1.15+0.2x	0.97+0.1x	0.880.0x	0.83+0.4x	0.41
Asset Turnover	0.130.0x	0.120.0x	0.110.0x	0.07-0.1x	0.13+0.1x	0.070.0x	0.100.0x	0.110.0x	0.100.0x	0.120.0x	0.130.0x	0.120.0x	0.120.0x	0.120.0x	0.12
FCF Margin	N/A	N/A	N/A	N/A	25.3%-53.8pp	79.1%+43.2pp	36.0%-1.3pp	37.3%-2.3pp	39.5%+4.7pp	34.9%-5.2pp	40.1%+2.5pp	37.5%-0.5pp	38.1%+6.7pp	31.3%-3.9pp	35.2%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	-15.4%+37.6pp	0.0%+15.0pp	3.8%+41.4pp	-19.4%+10.1pp	-53.1%-7.6pp	-15.0%+80.1pp	-37.5%-24.1pp	-29.5%-9.7pp
Return on Equity	-1.0%+2.3pp	0.0%+0.9pp	0.2%+2.5pp	-1.2%+0.5pp	-3.3%-0.8pp	-0.9%+4.0pp	-2.2%-1.6pp	-1.7%-0.7pp
Return on Assets	-0.5%+1.1pp	0.0%+0.4pp	0.1%+1.2pp	-0.6%+0.2pp	-1.5%-0.3pp	-0.4%+2.1pp	-1.1%-0.7pp	-0.8%-0.3pp
Debt-to-Equity	0.990.0x	0.920.0x	0.850.0x	0.96+0.1x	0.97+0.1x	0.93+0.1x	0.89+0.2x	0.90+0.2x
Asset Turnover	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Healthcare Tr Amer Inc HR	FY2025	$1.2B	-$249.5M	-21.1%	$6.6B	22/100
AMERICAN HEALTHCARE REIT INC AHR	FY2025	$2.3B	$70.8M	3.1%	$11.7B	53/100
Caretrust CTRE	FY2025	$476.4M	$320.5M	67.3%	$9.2B	58/100
Sabra Health Care Reit Inc SBRA	FY2025	$774.6M	$155.6M	20.1%	$5.3B	43/100
National Health Investors NHI	FY2025	$375.6M	$142.2M	37.9%	$3.4B	36/100
Medical Prop MPW	FY2025	$972.0M	-$277.0M	-28.5%	$3.0B	2/100

Where Healthcare Tr Amer Inc Ranks

Frequently Asked Questions

What is Healthcare Tr Amer Inc's annual revenue?

Healthcare Tr Amer Inc (HR) reported $1.2B in total revenue for fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Tr Amer Inc's revenue growing?

Healthcare Tr Amer Inc (HR) revenue declined by 6.9% year-over-year, from $1.3B to $1.2B in fiscal year 2025.

Is Healthcare Tr Amer Inc profitable?

No, Healthcare Tr Amer Inc (HR) reported a net income of -$249.5M in fiscal year 2025, with a net profit margin of -21.1%.

How much debt does Healthcare Tr Amer Inc have?

As of fiscal year 2025, Healthcare Tr Amer Inc (HR) had $26.2M in cash and equivalents against $3.9B in long-term debt.

What is Healthcare Tr Amer Inc's net profit margin?

Healthcare Tr Amer Inc (HR) had a net profit margin of -21.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Healthcare Tr Amer Inc pay dividends?

Yes, Healthcare Tr Amer Inc (HR) paid $1.10 per share in dividends during fiscal year 2025.

What is Healthcare Tr Amer Inc's return on equity (ROE)?

Healthcare Tr Amer Inc (HR) has a return on equity of -5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Tr Amer Inc's operating cash flow?

Healthcare Tr Amer Inc (HR) generated $457.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthcare Tr Amer Inc's total assets?

Healthcare Tr Amer Inc (HR) had $9.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Healthcare Tr Amer Inc buy back shares?

Yes, Healthcare Tr Amer Inc (HR) spent $4.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthcare Tr Amer Inc have outstanding?

Healthcare Tr Amer Inc (HR) had 349M shares outstanding as of fiscal year 2025.

What is Healthcare Tr Amer Inc's debt-to-equity ratio?

Healthcare Tr Amer Inc (HR) had a debt-to-equity ratio of 0.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthcare Tr Amer Inc's return on assets (ROA)?

Healthcare Tr Amer Inc (HR) had a return on assets of -2.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Tr Amer Inc's P/E ratio?

Healthcare Tr Amer Inc (HR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $6.6B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Tr Amer Inc's price-to-sales ratio?

Healthcare Tr Amer Inc (HR) trades at 5.7x sales, its market capitalization divided by revenue of $1.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.6B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Tr Amer Inc's Piotroski F-Score?

Healthcare Tr Amer Inc (HR) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Tr Amer Inc's earnings high quality?

Healthcare Tr Amer Inc (HR) reported a net loss of $249.5M while generating $457.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthcare Tr Amer Inc?

Healthcare Tr Amer Inc (HR) scores 22 out of 100 on our Financial Health Score, indicating weak standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.